Epidemiological Pattern of Lip Premalignant Lesions in an Iranian population: A 13-Year Evaluation
Journal of Dental School,
Vol. 39 No. 2 (2021),
13 April 2022
,
Page 54-56
https://doi.org/10.22037/jds.v39i2.35629
Abstract
Objectives This study investigated the prevalence and pattern of lip premalignant lesions in patients referred to the Cancer Institute of Imam Khomeini and Shohada-E-Tajrish Hospitals between 2004 and 2016.
Methods This retrospective cross-sectional study was conducted on the pathology reports of patients retrieved from the archives of the Pathology Departments of the Cancer Institute of Imam Khomeini and Shohada-E-Tajrish Hospitals between 2004 and 2016. The gender, age, lesion location (upper lip, lower lip, commissure, lip in general, not stated), pathological type, and clinical diagnosis of the lesions were extracted from patient records. The Fisher's Exact test was used to analyze the data by SPSS version 16.
Results Of a total of 237,392 patients, 40 (0.02%) cases had lip premalignant lesions. The mean age of patients was 63.71±14.11 years (range 3 to 92 years). The prevalence of lip premalignant lesions was higher in males, with a male to female ratio of 4:1. The most common location and histopathological type of lesions were the lower lip, and actinic keratosis (60% of the cases), respectively.
Conclusion Lip premalignant lesions were observed in 0.02% of patients. Although this rate is lower than the global prevalence of precancerous lesions of the lip and oral cavity (4.47%), because of the high malignant transformation rate of lip premalignant lesions, every clinician must take part in early detection of these lesions by clinical examination. To confirm the diagnosis, biopsy may be requested for histopathological diagnosis
- Lip
- Actinic cheilitis
- Actinic keratosis
- Keratoacanthoma
How to Cite
References
Saxena S, Gargava A, Gupta A, Verma P, Agrawal R. Clinico-histopathological study of premalignant lesions of oral cavity-A prospective observational study. Int J Health Clin Res. 2021;4(11):236-9.
Domínguez-Gordillo A, Esparza-Gómez G, García-Jiménez B, Cerero-Lapiedra R, Casado-Gómez I, Romero-Lastra P, et al. The pattern of lip cancer occurrence over the 1990-2011 period in public hospitals in Madrid, Spain. J Oral Pathol Med. 2016;45(3):202-10.
Maruccia M, Onesti MG, Parisi P, Cigna E, Troccola A, Scuderi N. Lip cancer: a 10-year retrospective epidemiological study. Anticancer Res. 2012;32(4):1543-6.
Casal D, Carmo L, Melancia T, Zagalo C, Cid O, Rosa-Santos J. Lip cancer: a 5-year review in a tertiary referral centre. J Plast Reconstr Aesthet Surg. 2010;63(12):2040-5.
Calcaianu N, Popescu SA, Diveica D, Lascar I. Surgical attitude in premalignant lesions and malignant tumors of the lower lip. J Med Life. 2015;8(1):109-11.
Mello FW, Miguel AFP, Dutra KL, Porporatti AL, Warnakulasuriya S, Guerra ENS, et al. Prevalence of oral potentially malignant disorders: A systematic review and meta-analysis. J Oral Pathol Med. 2018;47(7):633-40.
Sahoo PK, Sarkar S, Ghosh D, Mahata S, Pal R, Mistry T, et al. Premalignant and malignant lesions of oral cavity in eastern India: a hospital-based study. Eur J Cancer Prev. 2021;30(5):393-9.
Reddi SP, Shafer AT. Oral premalignant lesions: management considerations. Oral Maxillofac Surg Clin North Am. 2006;18(4):425-33.
Trager MH, Farmer K, Ulrich C, Basset-Seguin N, Herms F, Geskin LJ, et al. Actinic cheilitis: a systematic review of treatment options. J Eur Acad Dermatol Venereol. 2021;35(4):815-23.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-49.
Pakzad R, Soltani S, Salehiniya H. Epidemiology and trend in skin cancer mortality in Iran. J Res Med Sci. 2015;20(9):921-2.
Saghravanian N, Mohtasham N, Ivani F, Kadeh H, Shahrakipour M. The Epidemiological Pattern of Premalignant and Malignant Epithelial Lesions in Northeast of Iran: A 43-Year Evaluation. Int J Cancer Manag. 2017;10(8):e5403.
Sousa FB, Freitas e Silva MR, Fernandes CP, Silva PG, Alves AP. Oral cancer from a health promotion perspective: experience of a diagnosis network in Ceará. Braz Oral Res. 2014;28 Spec No:S1806-83242014000200006.
Maia HC, Pinto NA, Pereira JD, Medeiros AM, Silveira ÉJ, Miguel MC. Potentially malignant oral lesions: clinicopathological correlations. Einstein (Sao Paulo). 2016; 14:35-40.
Reinehr CPH, Bakos RM. Actinic keratoses: review of clinical, dermoscopic, and therapeutic aspects. An Bras Dermatol. 2019;94(6):637-57.
Takai T, Misago N, Murata Y. Natural course of keratoacanthoma and related lesions after partial biopsy: clinical analysis of 66 lesions. J Dermatol. 2015;42(4):353-62.
Lupu M, Caruntu A, Caruntu C, Boda D, Moraru L, Voiculescu V, et al. Non-invasive imaging of actinic cheilitis and squamous cell carcinoma of the lip. Mol Clin Oncol. 2018;8(5):640-6.
Chhabra N, Chhabra S, Sapra N. Diagnostic modalities for squamous cell carcinoma: an extensive review of literature-considering toluidine blue as a useful adjunct. J Maxillofac Oral Surg. 2015;14(2):188-200.
Han AY, Kuan EC, Mallen-St Clair J, Alonso JE, Arshi A, St John MA. Epidemiology of Squamous Cell Carcinoma of the Lip in the United States: A Population-Based Cohort Analysis. JAMA Otolaryngol Head Neck Surg. 2016;142(12):1216-23.
- Abstract Viewed: 182 times
- PDF Downloaded: 120 times